Clinical trial
Prevalence of Infection and Seroconversion and the Clinical Course of the Novel Coronavirus SARS-CoV-2 Infection in Children Between 0 to 18 Years of Age in Hamburg and Surroundings
NCT04534608 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Infection and Seroconversion and the Clinical Course of the Novel Coronavirus SARS-CoV-2 Infection in Children Between 0 to 18 Years of Age in Hamburg and Surroundings
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 11, 2020
- Completion date
- March 31, 2021
- Enrollment
- 6,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, sars-cov-2